Skip to main content
. 2022 Nov 25;13:1037239. doi: 10.3389/fphar.2022.1037239

TABLE 5.

Probability of target attainment for various predicted valproic acid daily dose using the final model.

Dose (mg/kg/day) AGE (year)
1–2 (%) 2–3 (%) 3–4 (%) 4–6 (%) 6–8 (%) 8–10 (%) 10–12 (%)
ABCB1 rs3789243 AG 15 21.86 26.17 32.77 45.32 59.71 70.36 73.89
20 78.80 76.77 77.75 83.3 83.23 71.60 55.89
25 96.58 97.99 96.56 81.98 63.25 48.59 33.29
30 78.14 73.83 67.23 54.68 40.29 29.63 15.26
35 45.17 45.84 42.79 33.68 22.53 13.41 3.95
ABCB1 rs3789243 AA 15 14.76 17.61 26.17 38.00 53.41 64.82 70.56
20 70.11 67.92 69.04 74.77 80.24 72.57 60.44
25 95.36 96.13 96.16 83.45 67.62 54.08 39.74
30 85.22 82.39 73.83 61.98 46.59 35.18 22.22
35 56.36 54.47 49.82 42.25 29.24 19.25 8.60
ABCB1 rs3789243 GG 15 6.44 7.88 14.43 28.41 43.55 55.60 65.66
20 55.96 54.69 57.69 64.54 72.46 70.36 60.70
25 89.00 87.44 86.43 83.22 72.36 60.36 47.03
30 92.7 91.48 85.21 70.47 56.32 44.40 30.92
35 70.53 66.16 60.82 51.73 39.96 29.67 17.57

Percentage represents the simulated patients who achieve target steady-state trough concentrations (50–100 mg/L) given the dose mentioned. Numbers in bold font indicate the PTA is greater than 70%.